FIELD: chemistry, biotechnologies.
SUBSTANCE: polypeptide represents proliferative factor (GIPF), as active start in production of medication for stimulation of epithelial cells proliferation in mammalian subject, providing for introduction to said subject of therapeutically efficient amount of said medication or for treatment of gastrointestinal disorder or damage of mucous membrane of oral cavity in mammalian subject.
EFFECT: extension of assortment of medications for stimulation of epithelial cells proliferation or for treatment of gastrointestinal disorder or damage of mucous membrane of oral cavity in mammalian subject.
15 cl, 223 dwg, 16 tbl, 37 ex
Title | Year | Author | Number |
---|---|---|---|
CLOSTRIDIAL TOXIN NetB | 2008 |
|
RU2474587C2 |
FUSED PROTEINS OF CARCINOEMBRYONAL ANTIGEN | 2005 |
|
RU2380375C2 |
POLYPEPTIDE AND IMMUNE MODULATION | 2014 |
|
RU2682651C2 |
USING SEQUENCE CODING C-TERMINAL HEAVY CHAIN DOMAIN OF TETANUS TOXIN AS THERAPEUTIC AGENT | 2008 |
|
RU2495676C2 |
NEW LIGAND OF CYTOKINE RECEPTOR ZCYTOR17 | 2003 |
|
RU2490276C2 |
NEW CYTOKINE ZALPHA 11-LIGAND | 2000 |
|
RU2258710C2 |
TUMOR POLYPEPTIDE ISOLATED FROM PROSTATE AND POLYNUCLEOTIDE ENCODING THEREOF | 1999 |
|
RU2234942C2 |
ANTIBODIES RECOGNISING CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS, AND METHODS OF USING SUCH | 2007 |
|
RU2461572C2 |
ISOLATED SOLUBLE IL-20 RECEPTOR (VARIANTS) | 2000 |
|
RU2279441C2 |
METHODS FOR LIPIDS OBTAINING | 2011 |
|
RU2636344C2 |
Authors
Dates
2009-01-10—Published
2005-01-27—Filed